GlycoMimetics, Inc.
GLYC
$0.2456
-$0.0291-10.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.66% | -4.39% | -4.62% | 12.07% | 20.97% |
| Total Depreciation and Amortization | -77.09% | -66.74% | -48.39% | -35.28% | -26.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.26% | 27.29% | 15.17% | 5.29% | -5.57% |
| Change in Net Operating Assets | 145.27% | 44.64% | 24.06% | 79.53% | 45.11% |
| Cash from Operations | 10.84% | 0.47% | -1.68% | 23.86% | 24.92% |
| Capital Expenditure | 53.74% | 48.06% | -22.37% | 42.05% | 74.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 193.93% | 48.06% | -22.37% | 42.05% | 74.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.98% | -99.98% | -99.79% | -99.73% | 593.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.98% | -99.98% | -99.79% | -99.73% | 593.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -411.25% | -1,479.29% | -1,515.07% | -192.87% | 85.66% |